BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 16552426)

  • 1. Confirmation of the R653Q polymorphism of the trifunctional C1-synthase enzyme as a maternal risk for neural tube defects in the Irish population.
    Parle-McDermott A; Kirke PN; Mills JL; Molloy AM; Cox C; O'Leary VB; Pangilinan F; Conley M; Cleary L; Brody LC; Scott JM
    Eur J Hum Genet; 2006 Jun; 14(6):768-72. PubMed ID: 16552426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A polymorphism, R653Q, in the trifunctional enzyme methylenetetrahydrofolate dehydrogenase/methenyltetrahydrofolate cyclohydrolase/formyltetrahydrofolate synthetase is a maternal genetic risk factor for neural tube defects: report of the Birth Defects Research Group.
    Brody LC; Conley M; Cox C; Kirke PN; McKeever MP; Mills JL; Molloy AM; O'Leary VB; Parle-McDermott A; Scott JM; Swanson DA
    Am J Hum Genet; 2002 Nov; 71(5):1207-15. PubMed ID: 12384833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A polymorphism in the MTHFD1 gene increases a mother's risk of having an unexplained second trimester pregnancy loss.
    Parle-McDermott A; Pangilinan F; Mills JL; Signore CC; Molloy AM; Cotter A; Conley M; Cox C; Kirke PN; Scott JM; Brody LC
    Mol Hum Reprod; 2005 Jul; 11(7):477-80. PubMed ID: 16123074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular genetic analysis of the gene encoding the trifunctional enzyme MTHFD (methylenetetrahydrofolate-dehydrogenase, methenyltetrahydrofolate-cyclohydrolase, formyltetrahydrofolate synthetase) in patients with neural tube defects.
    Hol FA; van der Put NM; Geurds MP; Heil SG; Trijbels FJ; Hamel BC; Mariman EC; Blom HJ
    Clin Genet; 1998 Feb; 53(2):119-25. PubMed ID: 9611072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moderate folic acid supplementation and MTHFD1-synthetase deficiency in mice, a model for the R653Q variant, result in embryonic defects and abnormal placental development.
    Christensen KE; Hou W; Bahous RH; Deng L; Malysheva OV; Arning E; Bottiglieri T; Caudill MA; Jerome-Majewska LA; Rozen R
    Am J Clin Nutr; 2016 Nov; 104(5):1459-1469. PubMed ID: 27707701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The MTHFD1 p.Arg653Gln variant alters enzyme function and increases risk for congenital heart defects.
    Christensen KE; Rohlicek CV; Andelfinger GU; Michaud J; Bigras JL; Richter A; Mackenzie RE; Rozen R
    Hum Mutat; 2009 Feb; 30(2):212-20. PubMed ID: 18767138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between MTHFD1 polymorphisms and neural tube defect susceptibility.
    Meng J; Han L; Zhuang B
    J Neurol Sci; 2015 Jan; 348(1-2):188-94. PubMed ID: 25524527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MTHFD1 formyltetrahydrofolate synthetase deficiency, a model for the MTHFD1 R653Q variant, leads to congenital heart defects in mice.
    Christensen KE; Deng L; Bahous RH; Jerome-Majewska LA; Rozen R
    Birth Defects Res A Clin Mol Teratol; 2015 Dec; 103(12):1031-8. PubMed ID: 26408344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal Mthfd1 disruption impairs fetal growth but does not cause neural tube defects in mice.
    Beaudin AE; Perry CA; Stabler SP; Allen RH; Stover PJ
    Am J Clin Nutr; 2012 Apr; 95(4):882-91. PubMed ID: 22378735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low Dietary Folate Interacts with MTHFD1 Synthetase Deficiency in Mice, a Model for the R653Q Variant, to Increase Incidence of Developmental Delays and Defects.
    Christensen KE; Bahous RH; Hou W; Deng L; Malysheva OV; Arning E; Bottiglieri T; Caudill MA; Jerome-Majewska LA; Rozen R
    J Nutr; 2018 Apr; 148(4):501-509. PubMed ID: 29659962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a methylenetetrahydrofolate-dehydrogenase 1958G>A polymorphism for neural tube defect risk.
    De Marco P; Merello E; Calevo MG; Mascelli S; Raso A; Cama A; Capra V
    J Hum Genet; 2006; 51(2):98-103. PubMed ID: 16315005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of common genetic variants in 82 candidate genes as risk factors for neural tube defects.
    Pangilinan F; Molloy AM; Mills JL; Troendle JF; Parle-McDermott A; Signore C; O'Leary VB; Chines P; Seay JM; Geiler-Samerotte K; Mitchell A; VanderMeer JE; Krebs KM; Sanchez A; Cornman-Homonoff J; Stone N; Conley M; Kirke PN; Shane B; Scott JM; Brody LC
    BMC Med Genet; 2012 Aug; 13():62. PubMed ID: 22856873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between maternal periconceptional supplementation of folic acid and reduced folate carrier gene polymorphism of neural tube defects.
    Pei LJ; Zhu HP; Li ZW; Zhang W; Ren AG; Zhu JH; Li Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Jun; 22(3):284-7. PubMed ID: 15952116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms in genes involved in folate metabolism as risk factors for NTDs.
    De Marco P; Calevo MG; Moroni A; Arata L; Merello E; Cama A; Finnell RH; Andreussi L; Capra V
    Eur J Pediatr Surg; 2001 Dec; 11 Suppl 1():S14-7. PubMed ID: 11813127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms of 5,10-methylenetetrahydrofolate reductase and cystathionine beta-synthase genes as a risk factor for neural tube defects in Sétif, Algeria.
    Houcher B; Bourouba R; Djabi F; Yilmaz E; Eğin Y; Akar N
    Pediatr Neurosurg; 2009; 45(6):472-7. PubMed ID: 20160465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MTHFR 677C-->T and 1298A-->C polymorphisms: evaluation of maternal genotypic risk and association with level of neural tube defect.
    Dalal A; Pradhan M; Tiwari D; Behari S; Singh U; Mallik GK; Das V; Agarwal S
    Gynecol Obstet Invest; 2007; 63(3):146-50. PubMed ID: 17085942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the MTHFD1 promoter and risk of neural tube defects.
    Carroll N; Pangilinan F; Molloy AM; Troendle J; Mills JL; Kirke PN; Brody LC; Scott JM; Parle-McDermott A
    Hum Genet; 2009 Apr; 125(3):247-56. PubMed ID: 19130090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epidemiological study on reduced folate carrier gene(RFC1 A80G) polymorphism and other risk factors of neural tube defects].
    Pei LJ; Li ZW; Zhang W; Ren AG; Zhu HP; Hao L; Zhu JH; Li Z
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Aug; 37(4):341-5. PubMed ID: 16086047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between the SLC19A1 gene and maternal first trimester fever on offspring neural tube defects.
    Pei L; Zhu H; Ye R; Wu J; Liu J; Ren A; Li Z; Zheng X
    Birth Defects Res A Clin Mol Teratol; 2015 Jan; 103(1):3-11. PubMed ID: 24917213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel mouse model for genetic variation in 10-formyltetrahydrofolate synthetase exhibits disturbed purine synthesis with impacts on pregnancy and embryonic development.
    Christensen KE; Deng L; Leung KY; Arning E; Bottiglieri T; Malysheva OV; Caudill MA; Krupenko NI; Greene ND; Jerome-Majewska L; MacKenzie RE; Rozen R
    Hum Mol Genet; 2013 Sep; 22(18):3705-19. PubMed ID: 23704330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.